To work within the chemotherapy service in the safe provision of anticancer treatment within Mid and South Essex NHS Trust.
To provide advice and support to patients, families and carers on all aspects of chemotherapy and cancer.
SACT Passport must be completed.
We are not able to offer sponsorship on any bank vacancies at MSE so all applicants must possess unrestricted right to work in the UK.
Responsibilities
* Inform and educate patients on the prescribed chemotherapy and its side effects.
* Counsel, support and educate patients and their carers on all aspects of their cancer journey, whether newly diagnosed or being treated with palliative intent.
* Ensure that the patient has consented to treatment and reconfirms agreement to treatment.
* Undertake patient assessment, recognition and recording of chemotherapy induced toxicities using common toxicity criteria.
* Recognise dose modifications required for cytotoxic drug toxicities.
* Protocol driven decision making regarding suitability for treatment – to include blood parameters and patient performance status.
Qualifications
* Must have had previous experience within this field.
* Undertake telephone triage for chemotherapy patients and their carers to ensure that potential treatment toxicities are treated appropriately and swiftly.
* Refer to support services as required e.g. palliative care, primary care, social services, occupational therapy, dietetics, physiotherapy and oncology counsellor, orthotics department.
* Ensure that the patient is rebooked for treatment and medical review at the appropriate time interval, and any pre-investigation forms are given to the patient.
* Document patient attendance in patient notes.
* Communicate and work with all members of the MDT to provide good care and symptom management.
* Ensure that practice adheres to local and national policies and guidelines to minimise the risk associated with cytotoxic drugs.
* Act within current Southend Hospital NHS Trust policies and guidelines of clinical practice.
This advert closes on Tuesday 12 May 2026.
#J-18808-Ljbffr